GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (NSE:INNOVACAP) » Definitions » YoY EBITDA Growth

Innova Captab (NSE:INNOVACAP) YoY EBITDA Growth : 16.51% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Innova Captab YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Innova Captab's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 16.51%.

Innova Captab's EBITDA per Share for the three months ended in Mar. 2025 was ₹8.91.

Innova Captab YoY EBITDA Growth Historical Data

The historical data trend for Innova Captab's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innova Captab YoY EBITDA Growth Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial -35.05 77.48 23.63 55.12 4.88

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.19 36.60 18.62 8.30 16.51

Innova Captab YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Innova Captab's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(34.631-33.019)/ | 33.019 |
=4.88 %

Innova Captab's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(8.911-7.648)/ | 7.648 |
=16.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innova Captab YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Innova Captab's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Innova Captab Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (NSE:INNOVACAP) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:524735 BOM:532872 BOM:506690 NSE:STAR BOM:524372 NSE:RPGLIFE BOM:512529 BOM:509079 BOM:543748 BOM:530549 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
544067:India
Address
SCO No. 301, Sector 9, Second Floor, Panchkula, HR, IND, 134109
Website
https://www.innovacaptab.com
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, and marketing and exports. Company business includes (i) a contract development and manufacturing organization ("CDMO") business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.

Innova Captab Headlines

No Headlines